Trading Day Triumph: Insulet Corporation (PODD) Ends at 250.25, a -0.81 Surge/Plunge

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

Insulet Corporation (NASDAQ: PODD) closed the day trading at $250.25 down -0.81% from the previous closing price of $252.29. In other words, the price has decreased by -$0.81 from its previous closing price. On the day, 0.6 million shares were traded. PODD stock price reached its highest trading level at $254.2 during the session, while it also had its lowest trading level at $248.4.

Ratios:

For a better understanding of PODD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 57.54. For the most recent quarter (mrq), Quick Ratio is recorded 2.73 and its Current Ratio is at 3.54. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 1.10.

On March 06, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $340.

On November 06, 2024, Bernstein started tracking the stock assigning a Outperform rating and target price of $300.Bernstein initiated its Outperform rating on November 06, 2024, with a $300 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 25 ’25 when Frederick Wayne A.I. sold 1,825 shares for $275.00 per share. The transaction valued at 501,875 led to the insider holds 3,231 shares of the business.

Frederick Wayne A.I. bought 1,825 shares of PODD for $501,875 on Mar 25 ’25. On Jan 21 ’25, another insider, Benjamin Eric, who serves as the EVP, CPXPO of the company, sold 12,394 shares for $280.00 each. As a result, the insider received 3,470,320 and left with 11,383 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PODD now has a Market Capitalization of 17608040448 and an Enterprise Value of 18054883328. As of this moment, Insulet’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.23, and their Forward P/E ratio for the next fiscal year is 47.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.48 while its Price-to-Book (P/B) ratio in mrq is 14.50. Its current Enterprise Value per Revenue stands at 8.715 whereas that against EBITDA is 46.33.

Stock Price History:

The Beta on a monthly basis for PODD is 1.27, which has changed by 0.43467295 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, PODD has reached a high of $289.46, while it has fallen to a 52-week low of $160.19. The 50-Day Moving Average of the stock is -3.61%, while the 200-Day Moving Average is calculated to be 1.94%.

Shares Statistics:

Over the past 3-months, PODD traded about 805.31K shares per day on average, while over the past 10 days, PODD traded about 639790 shares per day. A total of 70.20M shares are outstanding, with a floating share count of 69.90M. Insiders hold about 0.47% of the company’s shares, while institutions hold 101.92% stake in the company. Shares short for PODD as of 1744675200 were 2348117 with a Short Ratio of 2.92, compared to 1741910400 on 2881468. Therefore, it implies a Short% of Shares Outstanding of 2348117 and a Short% of Float of 4.4699997.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

The dynamic stock of Insulet Corporation (PODD) is currently being evaluated by a team of 18.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.88, with high estimates of $1.09 and low estimates of $0.77.

Analysts are recommending an EPS of between $5.18 and $3.85 for the fiscal current year, implying an average EPS of $4.18. EPS for the following year is $5.18, with 20.0 analysts recommending between $6.0 and $4.03.

Revenue Estimates

19 analysts predict $543.3M in revenue for the current quarter. It ranges from a high estimate of $551M to a low estimate of $536.5M. As of the current estimate, Insulet Corporation’s year-ago sales were $441.7MFor the next quarter, 19 analysts are estimating revenue of $577.79M. There is a high estimate of $594M for the next quarter, whereas the lowest estimate is $557.2M.

A total of 23 analysts have provided revenue estimates for PODD’s current fiscal year. The highest revenue estimate was $2.49B, while the lowest revenue estimate was $2.42B, resulting in an average revenue estimate of $2.45B. In the same quarter a year ago, actual revenue was $2.07BBased on 22 analysts’ estimates, the company’s revenue will be $2.87B in the next fiscal year. The high estimate is $2.98B and the low estimate is $2.77B.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.